Potential HIV cure Phase I trial gets FDA green light
Outsourcing Pharma
AUGUST 11, 2020
American Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.
Outsourcing Pharma
AUGUST 11, 2020
American Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.
pharmaphorum
AUGUST 10, 2020
Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The data mining tool will be used to try to unearth some of the many unknowns with the virus, using next-generation sequencing (NGS) to see how the genome of SARS-CoV-2 changes over time, along with patient genetic information, results of lung and CT scans,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
AUGUST 14, 2020
2022 will usher in the demise of third-party cookies—that means pharma brands must change their approach to targeting and measurement. For decades, the third-party cookie has been a core component of any digital marketing strategy, allowing advertisers to deliver targeted ads and measure their effectiveness. However, with increased consumer privacy concerns and regulations, third-party cookies are set to expire by 2022.
Druggist
AUGUST 8, 2020
With just one month to go, flu season 2020/2021 is just around the corner. It is expected to be that demand for flu vaccination service will be high this year. NHS England has an ambitious target for the uptake in eligible patients groups of at least 75%. Additionally, eligibility criteria will be extended, for example, phased-out eligibility for free flu vaccination of those aged 50-64.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Outsourcing Pharma
AUGUST 10, 2020
Experts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.
pharmaphorum
AUGUST 12, 2020
Author and journalist John-Manuel Andriote has spent much of his career writing about the impact of HIV/AIDS – a job that became much more personal when he himself was diagnosed in 2005. He tells pharmaphorum about the importance of resilience in coping with a serious illness. John first began writing about HIV/AIDS as a journalist in 1986. “I had two friends of mine in their 20s die from AIDS while I was in journalism school in 1985 – a time when AIDS was always in the news and there was a lot
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Druggist
AUGUST 8, 2020
With just one month to go, flu season 2020/2021 is just around the corner. It is expected to be that demand for flu vaccination service will be high this year. NHS England has an ambitious target for the uptake in eligible patients groups of at least 75%. Additionally, eligibility criteria will be extended, for example, phased-out eligibility for free flu vaccination of those aged 50-64.
Outsourcing Pharma
AUGUST 13, 2020
The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam.
pharmaphorum
AUGUST 10, 2020
Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour. Only ten minutes before I had a mental argument with myself, which I thought I had won, promising not to eat another one until tomorrow. The process that goes on inside our heads, affecting the good and bad choices we make regarding our health every day, is the focus of health psychology and the growing interest around behavioural change.
Pharma Times
AUGUST 13, 2020
If approved drug would offer a more flexible option for patients
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Druggist
AUGUST 14, 2020
Gaviscon range of products is probably the most known brand of antacids in the UK. There are, however, several alternative products and drugs which can be used to help with symptoms of heartburn and indigestion. Today I will review 16 best Gaviscon alternative products and medicines. I will briefly discuss what Gaviscon is to get a better understanding of alternative treatments.
Outsourcing Pharma
AUGUST 13, 2020
The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.
pharmaphorum
AUGUST 12, 2020
A new digital therapy is aiming to tackle depression during the COVID-19 pandemic, using a brain stimulation headset and therapy app that claims to have similar beneficial effects to drugs but with fewer side-effects. Flow is the first drug-free at-home treatment of its type to be approved in the EU and UK. While using the Flow headset, patients engaged with a therapy app program, which offers personalised behavioural therapy in areas proven to reduce symptoms of depression, including nutrition,
Pharma Times
AUGUST 11, 2020
Up to 750,000 unused testing kits to be recalled
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
AUGUST 14, 2020
2022 will usher in the demise of third-party cookies—that means pharma brands must change their approach to targeting and measurement. For decades, the third-party cookie has been a core component of any digital marketing strategy, allowing advertisers to deliver targeted ads and measure their effectiveness. However, with increased consumer privacy concerns and regulations, third-party cookies are set to expire by 2022.
Outsourcing Pharma
AUGUST 10, 2020
The company is joining with ICER to help promote use of robust, repeatable indirect comparisons in health tech assessments.
pharmaphorum
AUGUST 14, 2020
After ditching its home-grown attempt at a coronavirus contact-tracing app for smartphones, the UK is ready to start pilot trials of a second version based on a platform developed by Apple and Google. The new NHS Test and Trace app is intended to be used as an add-on to the controversial national and local contact-tracing service, and was due to start initial trials yesterday on the Isle of Wight and among a group of NHS volunteers.
Pharma Times
AUGUST 10, 2020
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Mirror
AUGUST 14, 2020
Animal feed represents the most profitable product type segment, presenting multiple investment opportunities for animal healthcare market operators. Top selling potential of animal feed additives is attributed to a growing focus on disease outbreak prevention rather than on curing disease afflicted animals. Animal healthcare market in China and Japan is especially observing robust demand growth.
Outsourcing Pharma
AUGUST 10, 2020
A leader from the clinical research solutions provider discusses the ways pandemic has shaken the trial industry, and how to tackle the obstacles.
pharmaphorum
AUGUST 14, 2020
Verona Pharma is to develop its lung drug ensifentrine for patients with COVID-19, joining the legions of drug companies repurposing their medicines to fight the pandemic. Based in the UK and US, Verona is due to start a phase 3 trial of ensifentrine in chronic obstructive pulmonary disease (COPD) later this year after encouraging results in phase 2.
Pharma Times
AUGUST 14, 2020
Company will manufacture over 25% more doses than previously planned
Pharma Mirror
AUGUST 14, 2020
QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable.
Outsourcing Pharma
AUGUST 12, 2020
A partnership between two trial tech providers aims to create a more powerful, efficient and effective study solution for sites, sponsors and CROs.
pharmaphorum
AUGUST 11, 2020
In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. Though Novo Nordisk is perhaps not as much of a household name as other pharma companies in the UK, it has a huge presence in diabetes, with a bigger market cap than the likes of GSK and AstraZeneca – and UK GM Pinder Sahota is keen to shout about the organisation that he describes as a “slee
Pharma Marketing Network
AUGUST 8, 2020
Great digital should be personal. As the Covid-19 environment continues to cause brands to shift more heavily toward digital and increase their non-physical tactics, it is important to remember this. We must work hard to keep these interactions personal. Personalization of content, experiences, and support services is already a mainstay of ecommerce and retail.
Pharma Mirror
AUGUST 14, 2020
The positive impacts of pharmacists in supporting medication without harm are described in a new publication from the International Pharmaceutical Federation (FIP) released today. The World Health Organization reports that one in four patients is harmed by the care they receive in primary and ambulatory care settings, including harm from medicines. It estimates the global.
Outsourcing Pharma
AUGUST 11, 2020
When growing market demand moved the Michigan CDMO to expand, it opted for a novel design-construction approach to building bigger digs.
pharmaphorum
AUGUST 10, 2020
Bristol-Myers Squibb’s Opdivo has improved survival in a trial involving patients with mesothelioma, a form of lung cancer, getting one up over rival checkpoint inhibitor Keytruda from Merck & Co. The results of the CheckMate-743 trial showed that a combination of Opdivo (nivolumab) with low-dose Yervoy (ipilimumab) reduced the risk of death by 26% compared to platinum-based chemotherapy after 22 months of follow-up.
Pharma Times
AUGUST 10, 2020
Phase III study of drug in Crohn's disease is ongoing
Pharma Mirror
AUGUST 13, 2020
Tadalafil is a prescription drug well-known to men over the age of 40 who usually have to deal with episodic or permanent erectile dysfunction. Yet there’s more to this substance than its typical use in managing impotence by improving the blood flow to the genitals. The substance is used in many other treatments and has. The post What Exactly Is Tadalafil?
Outsourcing Pharma
AUGUST 11, 2020
The medical organization has selected Rx.Health's TrialEngage, a set of digital tools geared toward supporting and improving decentralized trials.
pharmaphorum
AUGUST 14, 2020
Screening women for breast cancer in their 40s rather than their 50s could save lives, say the authors of a new Lancet Oncology study, although that finding has been challenged by other experts. Lowering the age that women start to routinely get mammograms was associated with a relative reduction in breast cancer mortality without leading to ‘over-diagnosis’ – in other words detecting minor changes that may not turn into full-blown cancers – according to the scientists.
Let's personalize your content